Aveanna Healthcare Holdings Inc. (AVAH) shares surged 9.96% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results and an upward revision of its full-year guidance.
The home healthcare provider reported Q1 revenue of $559.2 million, significantly surpassing the analyst consensus estimate of $513.1 million. This represents a robust 14% increase compared to the same period last year. The company's adjusted EBITDA also outperformed expectations, coming in at $67.4 million versus the forecasted $39.9 million.
Adding to the positive sentiment, Aveanna raised its full-year 2025 outlook. The company now projects revenue to exceed $2.15 billion, up from its previous guidance range of $2.10 - $2.12 billion. Additionally, the adjusted EBITDA forecast was increased to over $207 million, a substantial improvement from the earlier projected range of $190 - $194 million. This upward revision in guidance signals management's confidence in the company's growth trajectory and operational efficiency.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。